Cargando…
Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Qibai Pingfei capsule on chronic obstructive pulmonary disease
In this study, we have employed metabolomics technology in combination with network pharmacology to ascertain the key metabolites and hub genes. The objective was to explore the pathway of Qibai Pingfei Capsule (QBPF) in treating COPD through metabolomics. We identified 96 differential metabolites i...
Autores principales: | Xie, Jinghui, Liu, Mengxiang, Gao, Yating, Liu, Changan, Wu, Fan, Tong, Jiabing, Li, Zegeng, Zhu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618342/ https://www.ncbi.nlm.nih.gov/pubmed/37920214 http://dx.doi.org/10.3389/fphar.2023.1258138 |
Ejemplares similares
-
The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota
por: Jia, Yu, et al.
Publicado: (2022) -
Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases
por: Xie, Jinghui, et al.
Publicado: (2022) -
The Link between Circadian Clock Genes and Autophagy in Chronic Obstructive Pulmonary Disease
por: Hu, Yuedi, et al.
Publicado: (2021) -
The Pharmacological Mechanism of Guchangzhixie Capsule Against Experimental Colitis
por: Yan, Jing, et al.
Publicado: (2021) -
Deciphering the Pharmacological Mechanisms of Guizhi-Fuling Capsule on Primary Dysmenorrhea Through Network Pharmacology
por: Zhang, Siqin, et al.
Publicado: (2021)